Johnson & Johnson

(JNJ)

Health Care · Pharmaceutical Preparations · US

234.20

-0.9800 (-0.42%)

FINNHUB · 2h ago
Valuation Chart
Financial Statements
EDGAR · 1d ago
Line (USD)FY2025FY2024FY2023FY2022
Revenue94.19B88.82B85.16B94.94B
Pretax Income32.58B16.69B15.06B21.73B
Income Tax5.78B2.62B1.74B3.78B
Net Income26.80B14.07B35.15B17.94B
EPS (diluted)11.035.7913.726.73
Diluted Shares2.43B2.43B2.56B2.66B
Interest Expense772.00M276.00M
About

Employees: —
Key Ratios (TTM)
P/E21.26x
EV/EBITDA
EV/Sales6.28x
P/B6.99x
P/FCF28.93x
Operating margin
Net margin28.5 %
ROE32.9 %
Debt / Equity0.51x
Dividend yield
Revenue growth (YoY)6.0 %
EPS growth (YoY)90.5 %
Beta
EDGAR · 1d ago
News
An unhandled error has occurred. Reload 🗙

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.